294
Chem. Pharm. Bull. 57(3) 294—297 (2009)
Notes
Vol. 57, No. 3
Structure of New Monoterpene Glycoside from Sibiraea angustata RCHD.
and Its Anti-obestic Effect
Yoshiaki ITO,*,a Satoshi KAMO,a Samir Kumar SADHU,b Takashi OHTSUKI,b Masami ISHIBASHI,b and
Yoshihiro KANOc
a
Iskra Industry Co., Ltd.; 1–14–2 Nihonbashi, Chuo-ku, Tokyo 103–0027, Japan: b Graduate School of Pharmaceutical
Sciences, Chiba University; 1–33 Yayoi-cho, Inage-ku, Chiba 263–8522, Japan: and c Institute of Natural Medicine,
University of Toyama; 2630 Sugitani, Toyama 930–0194, Japan.
Received October 8, 2008; accepted December 19, 2008; published online January 8, 2009
A new monoterpene glycoside (1) isolated from the aerial part of Sibirae angustata RCHD. (Rosaceae) was
found to be 1-O-b -D-glucopyranosyl-geraniol-5,10-olide and named as sibiskoside. Acute toxicity study revealed
that oral administration of 1 (2.5 g/kg body weight) to mice resulted in no death and no evidence of abnormalities
in internal organs. Its oral administration to the mice reared with high-fat diet resulted in weight-loss, which was
also reflected in serum triglyceride and sugar level, and the weight of abdominal fat. Sibiskoside could be considered to be an active ingredient of Liucha for exerting weight-loss effect in a drink of S. angustata.
Key words
Sibiraea angustata; sibiskoside; monoterpene; serum triglyceride level; obesity-prevention
Sibiraea angustata RCHD. (Rosaceae) is a shrub found at
high-elevation dryland around 3000 to 4000 m height in the
areas of Xizang (Tibet), Sichuan, Qinghai, Gansu and Yunnan in China. The Tibetans believe that a long-term consumption of the aerial part of S. angustata as tea has some
benefit of health in humans. And they avoid mixing this plant
into sheep feed, since it has been practically known to cause
weight-loss during ingestion. It was no more than one of
folklores before our study. These traditions were not
recorded on any literature, but directly collected by our hearing from Tibetans. This folklore leads to the hypothesis that
the aerial part of S. angustata might have preventive effects
on obesity. Then, we had interest and study about the properties of S. angustata.
In the previous studies, 43 essential oils1) and glucityl ferulate (sibirate)2) were identified from the aerial part of S. angustata. The extract of S. angustata improved immune system3) and prevented CCl4-induced liver diseases.4) However,
the active ingredients for these pharmacological effects have
not yet been identified.
In this study, we present the isolation and structure determination of a new compound (1), together with two known
compounds, isoferulic acid and quercetin 3-O-a -L-arabinopyranosyl(1—6)-b -D-galactopyranoside5) from the aerial
part of S. angustata, and the anti-obestic effect of 1 is also
discussed.
sorption maximum at 220 nm (e ⫽13000). The 1H-NMR
spectrum indicated the presence of two tertiary methyl
groups [d H 1.61, 1.63, (each 3H, s)] and an anomeric proton
[d H 4.97 (1H, d, J⫽7.9 Hz)]. The 13C-NMR and DEPT spectra suggested the presence of two tertiary methyl groups,
three methylenes, seven methines, three quaternary carbons
including a carbonyl group. In addition, heteronuclear single
quantum correlation (HSQC) analysis suggested the presence
of a methine (d C 124.1) overlapped with a signal due to the
solvent (pyridine) (Table 1).
The chemical structure of the compound 1 was elucidated
by 1H–1H correlation spectroscoopy (COSY), nuclear overhauser effect spectroscopy (NOESY), HSQC and heteronuclear multiple bond correlation (HMBC) analyses (Fig. 1).
The connectives of these partial structures and the functional
groups were determined by analysis of HMBC. As shown in
Fig. 1, key long range correlations were observed between
the following proton and carbon signals: H-1 and C-2, C-3;
H-2 and C-4, C-10; H-4 (a and b ) and C-3, C-6; H-6 and C7, C-8, C-9; H-8 and C-6, C-7, C-9; H-9 and C-6, C-7, C-8;
H-1⬘ and C-1. Furthermore, NOESY spectrum exhibited
Table 1.
1
H- and 13C-NMR Spectrum Data for 1 in Pyridine-d5
Position
Aglycone
Results and Discussions
The aerial part of S. angustata was boiled in water and the
decoction was spray dried. The powdered extract was extracted with EtOH under reflux, and EtOH soluble part was
then concentrated under reduced pressure to give a brown
solid material. It was applied upon a charcoal column and
eluted with stepwise gradients of H2O–EtOH. From the 20%
EtOH fraction, compound 1 was obtained as colorless amorphous powder by preparative HPLC. It was established to
have a molecular formula of C16H24O8 by high resolutionpositive FAB-MS spectrum. Its IR spectrum showed absorption maxima exhibiting a lactone carbonyl (1745 cm⫺1) and
hydroxyl group (3354 cm⫺1). UV spectrum exhibited an ab∗ To whom correspondence should be addressed.
e-mail: y.ito@iskra.co.jp
Glc
1
2
3
4
5
6
7
8
9
10
1⬘
2⬘
3⬘
4⬘
5⬘
6⬘
dH
5.30 (2H, m)
6.56 (1H, m)
2.50, 2.95 (each, 1H, m)
5.21 (1H, m)
5.21 (1H, m)
1.63 (3H, s)
1.61 (3H, s)
4.97 (1H, d, J⫽8.0 Hz)
4.11 (1H, t, J⫽8.0 Hz)
4.28 (1H, m)
4.28 (1H, m)
3.95 (1H, m)
4.36, 4.52 (each, 1H, m)
dC
66.3
139.7
126.6
35.7
75.1
124.1
139.7
25.5
18.2
169.9
104.5
75.0
78.3
71.4
78.4
62.4
© 2009 Pharmaceutical Society of Japan
March 2009
cross-peaks between H-2 signal and both of signals due to H4 (a and b ). The carbonyl group at C-10 (d C 169.9) was inferred to be connected with an oxymethine carbon (C-5, d C
75.1) through a lactone-linkage since the oxymethine proton
(H-5) resonated at significantly low field (d H 5.21). Moreover, on acid hydrolysis, 1 afforded D-glucose which was
identified by TLC and [a ]D. In order to determine the absolute stereochemistry, 1 was converted into di-MTPA esters
through 4-steps reactions (Chart 1). By applying Kusumi–
Mosher method6) for these MTPA esters (8a, b), the absolute
configuration of C-5 of 1 was suggested as R as shown in
Fig. 1. Thus, the structure of 1 was determined as 1-O-b -Dglucopyranosyl-geraniol-5,10-olide.
Acute toxicity experiments revealed that 1 was extremely
low toxic. The oral LD50 value for mice was more than
2500 mg/kg. In both sexes, there were no difference in general condition, body weight and food intakes in all groups
(data not shown). No deaths were observed in all groups.
295
The experiment of evaluation of 1 for the effect on the
body weight of mice reared with high-fat diet was conducted.
Before mice were feeded with high-fat diet, there were no
significant differences of body weight among the 2 experimental groups. Then, the mice were reared with high-fat diet
with or without 1 as drinking water for 42 d. The intakes of
the feed and water were not significantly different between
control and the group treated with 1 (Fig. 2). In the preliminary study, the body weight of control group reared with
high-fat diet was confirmed to be increased compared with
normal mice fed with usual diet (data not shown). The
weight of mice treated with 1 was significantly lower than the
control group from day 21 to 42 (Fig. 3), suggesting that 1
Fig. 2. Profiles of Food (A) and Water (B) Intake in the Mice Rared with
High-Fat Diet with or without 1
Fig. 1.
Chart 1.
Chemical Structure of 1
Conversion of 1 to MTPA Esters (8a, b) and D d Values of 8a and 8b
Open circle, control group; closed circle, 1-treated group. Data were 1 d food intake
of 5 mice.
296
Vol. 57, No. 3
Table 3.
Fat
Effect of Compound 1 on Weight of Liver and Intra-abdominal
Weight of fat (g) around
Group
Control
Compound 1
Weight of
liver (g)
Kidney
Posterior
abdominal wall
1.40⫾0.22 0.116⫾0.113 0.291⫾0.120
1.12⫾0.12 0.035⫾0.010 0.186⫾0.096
Epididymis
1.540⫾0.559
0.445⫾0.215**
Data are expressed as mean⫾S.E. of five mice. ∗∗ p⬍0.01 vs. control group.
Fig. 3.
Profiles of Body Weight of the Mice Treated with Compound 1
Open circle, control group; closed circle, compound 1-treated group. Data were expressed as mean⫾S.E. ∗ p⬍0.05, ∗∗ p⬍0.01 vs. control group.
Table 2.
Effect of Compound 1 on Blood Biochemical Values
Blood biochemical values (mg/dl)
Group
Control
Compound 1
Total
cholesterol
Triglyceride
161⫾30
118⫾22*
94⫾22
26⫾16**
Blood glucose
level
228⫾20
183⫾36*
Data were expressed as mean⫾S.E. of five mice. ∗ p⬍0.05 and ∗∗ p⬍0.01 vs. control
group.
has suppressive effect on the increase of body weight. At day
42, mice were sacrificed and the blood was corrected and the
weights of fat around the kidney, the posterior abdominal
wall and the epididymis were measured. As shown in Table
2, total cholesterol (TC), triglyceride (TG) and blood glucose
(BG) levels were significantly lower than those of control
group. Weights of liver, fat around the kidney and the posterior abdominal wall were slightly lower than the control without statistically significant difference. However, the weight of
fat around the epididymis was significantly lower than that in
control (Table 3). That is, it was suggested that 1 would have
the effect of lowering body fat, particularly, viscous fat, or
would have suppressive effect on the accumulation of fat. It
is expected that 1 had an action of ameliorating obesity. Although we are unable to clearly describe the mechanism behind the ameliorating obesity effect of 1, the administration
of 1 did significantly affect the plasma levels of TC, TG, and
BG. It is speculated that compound 1 might suppress the increase in body weight in the mice reared with high-fat diet by
the inhibition of TG absorption.
Lipids are known to be an important energy source, but
excess intake may induce obesity and hyperlipidemia. Obesity is an independent risk factor for cardiac disease7) which
has been associated conditions such as hypertension and diabetes. For example, as with other heart failure risk factors,
obesity frequently leads to left ventricular hypertrophy,8—11)
and because of its epidemic nature in developed societies,
obesity is a very important public health problem.12,13) Keeping the body weight level within the normal range is important for the prevention of variety diseases such as arteriosclerosis, cerebral apoplexy and myocardial infarction etc. So far,
S. angustata has been known as the plant with beneficial ef-
fects on health, however, the effect of 1 has never been reported. In this study, the possibility was suggested by new
molecular entity “compound 1” discovered from S. angustata
as a preventive medicine of the obesity syndrome. We are
currently running an additional study to evaluate the mechanism of compound 1.
Experimental
General 1H- and 13C-NMR spectra were measured on Varian unity
Inova-500 (1H, 500 MHz; 13C, 125 MHz, Varian Co., CA, U.S.A.) spectrometers. Chemical shift values are given in ppm using TMS as an internal standard. MS spectra were obtained using a JOEL JMS-HX110A mass spectrometer (JEOL Ltd., Tokyo). Optical rotations were measured on a JASCO
P-1020 polarimeter (JASCO Ltd., Tokyo). IR spectra were measured on a
JASCO FT-IR 230 spectrometer.
Plant Material The plant material of S. angustata cultivated in the field
of Apa in Sichuan province of China in 2002 was used in this study. This
plant was identified by professor Wang Tian Zhi in West China School of
Pharmacy, Sichuan University.
Extraction and Isolation One hundred kilograms of the aerial part of S.
angustata was extracted twice with boiling water of 1000 l for 1 h, and the
decoction was pulverized by spray dry method, yielding 33.7 kg of the extract. The powdered extract (3.0 kg) was eluted with EtOH (3 l⫻3) under reflux, and the EtOH eluate was concentrated under reduced pressure to give a
brown solid material (1.3 kg). One kilogram of this material was applied
upon a charcoal (Charcoal Activated, Wako, Osaka) column chromatography, and eluted successively with stepwise gradients of H2O–EtOH (20%,
40%, 60%, 90%, 100% EtOH). The 20% EtOH fraction was concentrated
under reduced pressure to give a brown solid material (98 g). Seventy-two
grams of the fraction was applied upon a silica-gel (Silicagel 60 N, Merck
Japan, Tokyo) column chromatography, and eluted with EtOAc to give fractions (Fr. A-1—A-4). Fr. A-3 (15 g) was purified by preparative HPLC (column, Cosmosil 5C18-AR-II, 20f ⫻250 mm, Nacalai, Kyoto; mobile phase,
25% MeOH, 8 ml/min) to give compound 1 (1.2 g) at the retention time,
54 min. Furthermore, compound 2 (2.5 g) was obtained from 90% EtOH
fraction of charcoal column chromatography by repeated recrystallization
and identified as isoferulic acid by comparison of spectral data with those of
authentic sample (Tokyo Chemical Industry Co., Tokyo).
On the other hand, the EtOH eluate (1.4 kg) was applied upon a Diaion
HP-20 resin (Mitsubishi Chemical Co., Tokyo) column chromatography, and
eluted successively with stepwise gradients of H2O–MeOH (20%, 50%,
80%, 100% MeOH) and acetone. The 50% MeOH fraction was concentrated
under reduced pressure to give a brown solid material (220 g). Fifty grams of
the material was applied upon a silica-gel column and eluted successively
with CHCl3 : MeOH : H2O⫽9 : 1 : 0.1, 8 : 2 : 0.1, 7 : 3 : 0.2, 7 : 3 : 0.5, 6 : 4 : 1,
5 : 5 : 1, and MeOH to give fractions (Fr. B-1—B-9). Compound 3 was obtained from Fr. B-7 by recrystallization, and identified as quercetin 3-O-a -Larabinopyranosyl(1→6)-b -D-galactopyranoside (190 mg) by comparison of
spectral data.
1-O-b -D-Glucopyranosyl-geraniol-5,10-olide (1) Colorless amorphous
powder. [a ]D22 ⫺20° (c⫽1.0, MeOH); 1H- and 13C-NMR spectra: see Table
1; HR-positive FAB-MS, m/z: 367.1369 [M⫹Na]⫹ (Calcd for C16H25O8Na;
367.1368); UV (MeOH): l max 220 (e ⫽13000); IR (NaCl, cm⫺1): 3354
(OH), 1745 (C⫽O).
Acid Hydrolysis of 1 Compound 1 (50 mg) was heated in 1 N HCl
(3 ml) at 80 °C for 5 h and neutralized by passing through an ion-exchange
resin (Amberlite IRA410J, OH⫺ form, Organo Co., Tokyo) column. The reaction mixtures were applied upon Wakogel 100C18 (Wako Pure Chemical
Industries, Osaka) column and eluted with H2O to give sugar fraction.
March 2009
The monosaccharide were identified as D-glucose by [a ]D21 ⫹66.9° (c⫽
0.48, H2O) and TLC using Silica gel 60 (Merck Japan, Tokyo) with
EtOAc : AcOH : MeOH : H2O⫽12 : 3 : 3 : 2 to give Rf value 0.6, which is fitted to standard D-glucose.
Preparation of MTPA Esters from 1 Compound 1 (140 mg) was subjected to enzyme hydrolysis by treatment with naringinase (700 mg) in acetone buffer (50 mM, pH 5.5; acetic acid 45.3 mg, anhydrous sodium acetate
348 mg and H2O up to 100 ml) at 37 °C for 16 h. The aqueous solution was
extracted with EtOAc (50 ml⫻3) followed by HPLC purification (YMCPack ODS-AM, 10⫻250 mm; flow rate, 2 ml/min; RI detection) to give
aglycone (29.5 mg). The aglycone (20 mg) was treated with trimethyldimethylsilyl chloride (20 mg) in the presence of triethylamine (24 m l) and
4-dimethylaminopyridine (2 mg) in CH2Cl2 (0.7 ml) at room temperature for
18 h under argon atmosphere. The reaction mixture was evaporated and purified with a silica gel column chromatography with hexane/acetone (3 : 1) to
give a TBDMS ether (6.2 mg), which was then reduced with LiAlH4 (4 mg)
in THF (0.4 ml) at room temperature for 10 min. After addition of 1 N HCl,
extraction with EtOAc and evaporation of the organic layer afforded diol
(2.1 mg). A part of the diol (0.5 mg) was treated with (R)-MTPACl (5 m l) in
pyridine (100 m l) at room temperature for 24 h. After addition of H2O, extraction with EtOAc followed by purification with silica gel column chromatography with CHCl3/acetone (9 : 1) afforded the (S)-MTPA ester (8a)
(0.4 mg). 1H-NMR (CDCl3) d 4.08 and 4.20 (each 1H, m, H2-1), 0.86 and
1.28 (each 1H, m, H2-2), 1.51 (1H, m, H-3), 1.09 and 1.54 (each 1H, m, H24), 3.99 (1H, m, H-5), 5.10 (1H, m, H-6), 1.64 (3H, m, H3-9), 3.51 and 4.03
(each 1H, m, H2-10), 1.23 (9H, s, t-Bu and 0.048 (6H, s, CH3⫻2). Treatment
of the diol (0.5 mg) with (S)-MTPACl by the same procedures afforded the
(R)-MTPA ester (8b) (0.4 mg). 1H-NMR (CDCl3) d 4.08 and 4.20 (each 1H,
m, H2-1), 0.86 and 1.27 (each 1H, m, H2-2), 1.51 (1H, m, H-3), 1.08 and
1.54 (each 1H, m, H2-4), 3.97 (1H, m, H-5), 5.10 (1H, m, H-6), 1.69 (3H, s,
H3-8), 1.64 (3H, s, H3-9), 3.51 and 4.01 (each 1H, H2-10), 1.23 (9H, s, t-Bu)
and 0.046 (6H, s, CH3⫻2).
Compound 2: White amorphous solid, [a ]D24 ⫺0.79° (c⫽2.0, MeOH);
HR-EI-MS, m/z: 182.0950 (M⫹) (Calcd for C10H14O3 ; 182.0943); 1H-NMR
data in CDCl3: d 1.72 (3H, s, H-9), 1.75 (3H, s, H-8), 2.63 and 3.06 (each
1H, m, H-4), 4.56 (2H, m, H-1), 5.20 (1H, m, H-5), 5.21 (1H, m, H-6), 6.37
(1H, m, H-2); 13C-NMR data in CDCl3: d 18.3 (C-9), 25.7 (C-8), 36.0 (C-4),
58.9 (C-1), 75.5 (C-5), 122.8 (C-6), 127.4 (C-3), 140.4 (C-7), 141.5 (C-2),
170.6 (C-10).
Acute Toxicity Test for Compound 1 Ten mice per group of each sex
weighing 18—22 g were used. Compound 1 suspended in water was orally
administered at the dose of 500—2500 mg/kg. Toxic sighs and mortality
were monitored up to day 14 when the test was terminated. LD50 value was
calculated by the Litchfield–Wilcoxon method. All procedures involving animal studies were conducted in accordance with the Guidelines for Animal
Experiments by New Drug Development Research Center, Inc., and SunTen
Phytotech Co., Ltd.
Effect of Compound 1 on the Body Weight of Mice Reared with HighFat Diet Six week-old ddY male SPF mice weighing 25—30 g were purchased from Japan SLC (Hamamatsu). The animals were housed at 22⫾3 °C
297
subjected to a 12 h light–dark cycle and 50⫾20% relative humidity with
food and water available ad libitum. The mice were kept for 1 week before
the experiment. Thereafter, the obesity mice model was induced by feeding a
high fat diets (lard 40%, corn starch 10%, granulated sugar 9%, mineral mix
4%, vitamin mix 1%, casein 29%, cellulose 5%, lactose 2%, Nosan Co.,
Yokohama, Day 0). For the treated group (n⫽5) with compound 1, the compound was suspended in water with the concentration prepared at the dose of
250 mg/kg/d (2.5 mg/ml, mice weight 20 g; 2.9 mg/ml, 30 g; 3.3 mg/ml,
40 g), and administrated as drinking water freely from day 0 to 42. In control
group, water was administered instead of compound 1. The body weight of
the mice was measured at a frequency of once a week during the feeding period with the high fat diet. On day 42, mice were anesthetized with intraperitoneal injection of pentobarbital (50 mg/kg), and whole blood was taken
from the inferior vena cava with a sterile syringe anticoagulated with heparin lithium. Immediately after the collection of blood samples, the mice
were exsanguinated and necropsied, and the liver, fat around kidney, posterior abdominal wall and epididymis were weighted. The plasma was obtained by centrifugation (1870⫻g for 10 min) and stored at ⫺80 °C until
use. The plasma clinical chemistry was analyzed using a Hitachi 7070 Automatic Serum Analyzer (Hitachi Ltd., Tokyo). The concentrations of TC, TG
and BG level were measured. The reagents used for the assays of TC, TG,
and BG were purchased from Wako.
Statistical Analysis Data are shown as the mean⫾standard error (S.E.),
and p⬍0.05 statistically analysed by Student’s t-test was considered as significant.
Acknowledgements We thank Professor Wang Tian Zhi of West China
School of Pharmacy, Sichuan University for identification of the plant.
References
1) Tao T., Bai C., Wang T., Du L., Huaxi Yaoxue Zazhi, 19, 178—179
(2004).
2) Zhang C. Z., Li C., Feng S. L., Zhao C. L., Wang W. H., Acta Pharm.
Sin., 28, 798—800 (1993).
3) Liu X., Yang P., Pan X., Mianyixue Zazhi, 12, 237—240 (1996).
4) Wang X., Yang B., Chin. J. Chin. Mater. Med., 20, 746—748 (1995).
5) Takemura M., Nishida R., Mori N., Kuwahara Y., Phytochemistry, 61,
135—140 (2002).
6) Ohtani I., Kusumi T., Kashman Y., Kakisawa H., J. Am. Chem. Soc.,
113, 4092—4096 (1991).
7) Sowers J. R., Am. J. Med., 115, 37S—41S (2003).
8) Paulson D. J., Tahiliani A. G., Life Sci., 51, 1557—1569 (1992).
9) Aipert M. A., Hashimi M. W., Am. J. Med. Sci., 306, 117—123 (1993).
10) Kasper E. K., Hruban R. H., Baughman K. L., Am. J. Cardiol., 70,
921—924 (1992).
11) Kenchaiah S., Evans J. C., Levy D., Wilson P. W., Benjamin E. J., Larson M. G., Kannel W. B., Vasan R. S., N. Engl. J. Med., 347, 305—313
(2002).
12) Bray G. A., Ryan D. H., Endocrine, 13, 167—186 (2000).
13) Pi-Sunyer F. X., Ann. Intern. Med., 119, 665—670 (1993).